Sotatercept, an activin-signaling inhibitor, reduces morbidity and mortality among patients with long-standing pulmonary ...
Apreo Health today announced positive study results for its novel, self-expanding Breathe nitinol airway scaffold.
Abivax Announces Acceptance of Additional Late-Breaking Abstract from the ABTECT Phase 3 Induction Trials to be Presented at 2025 United European ...
The presentations will be available on Connect’s website under the publications and presentations section.
Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other ...
In early September, RemeGen announced the acceptance by the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) in China of its Biologics License Application (BLA) ...
Behavioral variability is quietly sabotaging clinical trials—but it doesn't have to. Here's how predictive behavioral modeling can improve trial design, reduce dropout, and deliver more inclusive, ...
Unified data also improves AI outputs. For example, by drawing up-to-date information from a variety of an organization’s ...
On September 27, 2024, Rwanda reported an outbreak of Marburg virus disease (MVD), after a cluster of cases of viral hemorrhagic fever was detected at two urban hospitals. We report key aspects of the ...
JCR Pharmaceuticals Presents Long-Term Clinical Data on Pabinafusp Alfa for the Treatment of Mucopolysaccharidosis Type II (MPS II) at ICIEM 2025 – Oral Presentation Highlights Long-Term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback